Hepatosplenic T-Cell Lymphoma Completed Phase 1 Trials for Azacitidine (DB00928)

Also known as: Alpha-beta and gamma delta types

IndicationStatusPhase
DBCOND0040132 (Hepatosplenic T-Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01129180Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell LymphomaTreatment